• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    5/28/24 1:24:16 PM ET
    $ABL
    $AGIO
    $AKAN
    $APDN
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABL alert in real time by email

    Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) fell sharply during Tuesday's session after the company announced the pricing of a $12 million public offering.

    Applied DNA Sciences shares tumbled 67.5% to $0.6468 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Sharps Technology, Inc. (NASDAQ:STSS) shares climbed 207% to $0.6579 after jumping around 13% on Friday.
    • Insmed Incorporated (NASDAQ:INSM) jumped 110% to $46.20 after the company announced topline results from ASPEN Phase 3 study met its primary endpoint.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares gained 91.5% to $0.3411 after the company on Friday announced its SUNation subsidiary signed a 1.95-megawatt project.
    • Calliditas Therapeutics AB (NASDAQ:CALT) shares gained 74.6% to $38.10 after the company’s board recommended the acceptance of Asahi Kasei’s tender offer.
    • Visionary Holdings Inc. (NASDAQ:GV) rose 68% to $0.3350. Visionary Holdings said that the company has successfully transformed into a high-innovation and high growth company.
    • Oblong, Inc. (NASDAQ:OBLG) surged 57% to $0.2841.
    • Latam Logistic Properties, S.A. (NYSE:LPA) rose 45.2% to $20.47.
    • Predictive Oncology Inc. (NASDAQ:POAI) jumped 37% to $2.1801 after the company announced results from its ovarian caner study with UPMC Magee-Womens Hospital.
    • Trinity Place Holdings Inc. (NASDAQ:TPHS) rose 35% to $0.1837.
    • Exicure, Inc. (NASDAQ:XCUR) gained 31% to $0.4359.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) rose 30% to $1.1000.
    • Kuke Music Holding Limited (NYSE:KUKE) gained 24.2% to $3.2781. Kuke Music signed a non-binding term sheet with Naxos One Holding.
    • Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) rose 22% to $38.29 after the company announced it agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) gained 21% to $36.63 after the company announced it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 19.3% to $0.1205 after dipping over 10% on Friday.
    • Ocean Power Technologies, Inc. (NASDAQ:OPTT) shares gained 16.7% to $0.2240 after gaining around 5% on Friday.
    • GameStop Corp. (NYSE:GME) gained 14.4% to $0.3411 after the company announced it has completed its at-the-market equity offering program, which was previously announced.
    • Corcept Therapeutics Incorporated (NASDAQ:CORT) climbed 13.7% to $31.20 after the company announced that its Phase 3 GRACE trial met its primary endpoint.
    • Forward Air Corporation (NASDAQ:FWRD) rose 13% to $13.93.
    • NuScale Power Corporation (NYSE:SMR) gained 11.7% to $8.68 after jumping over 16% on Friday.
    • Nukkleus Inc. (NASDAQ:NUKK) rose 10.9% to $1.0201.
    • Abacus Life, Inc. (NASDAQ:ABL) gained 10.1% to $11.78.
    • Oklo Inc. (NYSE:OKLO) rose 10.1% to $11.18.
    • HubSpot, Inc. (NYSE:HUBS) gained 6.9% to $631.00.

    Losers

    • Marpai, Inc. (NASDAQ:MRAI) shares fell 54.7% to $0.6468 after the company announced its intention to withdraw from the Nasdaq hearings process.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) shares fell 47.4% to $0.5170 after surging 428% on Friday.
    • Sintx Technologies, Inc. (NASDAQ:SINT) fell 41% to $8.00.
    • Netcapital Inc. (NASDAQ:NCPL) dipped 27.7% to $0.1390 after the company announced that it entered into definitive agreement for the immediate exercise of $2.2 million of certain outstanding Series A-2 warrants.
    • OneMedNet Corporation (NASDAQ:ONMD) shares fell 24.4% to $1.77 after jumping 56% on Friday. OneMedNet, last week, highlighted a ‘five-fold expansion’ of its iRWD network and platform.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) fell 22.8% to $2.61.
    • Akanda Corp. (NASDAQ:AKAN) shares fell 18.5% to $3.35 following a 72% surge on Friday. The international medical cannabis company implemented a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, according to a recent exchange filing.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) fell 17.8% to $8.25.
    • G1 Therapeutics, Inc. (NASDAQ:GTHX) declined 17.6% to $3.37.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) fell 15.6% to $1.8399.
    • HilleVax, Inc. (NASDAQ:HLVX) fell 13.6% to $11.14.
    • Celsius Holdings, Inc. (NASDAQ:CELH) dipped 13.3% to $82.08.
    • Ryde Group Ltd. (NYSE:RYDE) declined 12.6% to $9.38.
    • Novavax, Inc. (NASDAQ:NVAX) fell 12.4% to $13.56.
    • NWTN Inc. (NASDAQ:NWTN) declined 12.3% to $3.52. NWTN received expected notification from the Nasdaq related to delayed annual report on Form 20-F.
    • DraftKings Inc. (NASDAQ:DKNG) dipped 11% to $36.29 after the Illinois Senate approved a 2025 budget that includes a sports betting tax hike.
    • Merus N.V. (NASDAQ:MRUS) fell 9.5% to $54.28 as the company revealed interim results for bispecific antibody petosemtamab with pembrolizumab at 2024 American Society of Clinical Oncology Annual Meeting.
    • Moderna, Inc. (NASDAQ:MRNA) dipped 9.2% to $151.28.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declined 9.1% to $112.24 after RBC Capital downgraded the stock from Outperform to Sector Perform.
    • Minim, Inc. (NASDAQ:MINM) shares fell 8.6% to $3.91 after gaining 33% on Friday.
    • Applied UV, Inc. (NASDAQ:AUVI) shares fell 8.5% to $0.2879. Applied UV shares fell around 34% on Friday after the company reportedly filed for Chapter 11 bankruptcy.
    • Loar Holdings Inc. (NYSE:LOAR) declined 7% to $51.36.
    • Sea Limited (NYSE:SE) declined 6% to $67.75 after the company’s Shopee was reportedly accused of suspected anti-competition breaches in Indonesia.
    • Hello Group Inc. (NASDAQ:MOMO) fell 5.8% to $5.20 following first-quarter results.

    Now Read This: $1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

    Get the next $ABL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABL
    $AGIO
    $AKAN
    $APDN

    CompanyDatePrice TargetRatingAnalyst
    Oklo Inc.
    $OKLO
    4/23/2026$96.00Buy
    HSBC Securities
    NuScale Power Corporation
    $SMR
    4/23/2026$13.00Hold
    HSBC Securities
    Agios Pharmaceuticals Inc.
    $AGIO
    4/20/2026$65.00 → $50.00Buy
    H.C. Wainwright
    Celsius Holdings Inc.
    $CELH
    4/20/2026$66.00 → $55.00Buy
    TD Cowen
    SiNtx Technologies Inc.
    $SINT
    4/13/2026$10.00Buy
    H.C. Wainwright
    Insmed Incorporated
    $INSM
    4/10/2026$200.00Outperform
    Raymond James
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    HubSpot Inc.
    $HUBS
    3/31/2026$300.00Buy
    BofA Securities
    More analyst ratings

    $ABL
    $AGIO
    $AKAN
    $APDN
    SEC Filings

    View All

    SEC Form 20-F filed by Ryde Group Ltd.

    20-F - Ryde Group Ltd (0001971115) (Filer)

    4/24/26 6:06:09 AM ET
    $RYDE
    Real Estate

    SEC Form DEFA14A filed by Virgin Galactic Holdings Inc.

    DEFA14A - Virgin Galactic Holdings, Inc (0001706946) (Filer)

    4/21/26 4:48:43 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    Edible Garden AG Incorporated filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Edible Garden AG Inc (0001809750) (Filer)

    4/21/26 4:30:26 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $ABL
    $AGIO
    $AKAN
    $APDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oklo, NVIDIA, and Los Alamos National Laboratory Collaborate to Advance Nuclear Fuel Validation at Los Alamos in Support of Nuclear-Powered AI Factories

    The agreement brings together advanced nuclear reactors, AI models, and national laboratory expertise to support critical nuclear infrastructure for the federal government's Genesis Mission. Oklo Inc. (NYSE:OKLO) ("Oklo"), an advanced nuclear technology company, today announced an agreement with NVIDIA, a leader in AI and accelerated computing, and Los Alamos National Laboratory (LANL), to advance critical nuclear infrastructure, AI-enabled research, and nuclear fuel R&D at Los Alamos. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423742786/en/Oklo Aurora powerhouse (Image: Oklo) The collaboration is intended to combine ad

    4/23/26 8:00:00 AM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    $ABL
    $AGIO
    $AKAN
    $APDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HSBC Securities initiated coverage on Oklo Inc. with a new price target

    HSBC Securities initiated coverage of Oklo Inc. with a rating of Buy and set a new price target of $96.00

    4/23/26 7:56:23 AM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    HSBC Securities initiated coverage on NuScale Power with a new price target

    HSBC Securities initiated coverage of NuScale Power with a rating of Hold and set a new price target of $13.00

    4/23/26 7:56:23 AM ET
    $SMR
    Metal Fabrications
    Industrials

    H.C. Wainwright reiterated coverage on Agios Pharma with a new price target

    H.C. Wainwright reiterated coverage of Agios Pharma with a rating of Buy and set a new price target of $50.00 from $65.00 previously

    4/20/26 12:09:42 PM ET
    $AGIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABL
    $AGIO
    $AKAN
    $APDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Levy Paul S bought $4,867,500 worth of shares (75,000 units at $64.90) (SEC Form 4)

    4 - Loar Holdings Inc. (0002000178) (Issuer)

    3/17/26 4:16:58 PM ET
    $LOAR
    Military/Government/Technical
    Industrials

    Director Carpenito Anthony bought $311,857 worth of shares (4,800 units at $64.97) (SEC Form 4)

    4 - Loar Holdings Inc. (0002000178) (Issuer)

    3/13/26 5:35:06 PM ET
    $LOAR
    Military/Government/Technical
    Industrials

    Director Bobbili Raja bought $3,180,486 worth of shares (50,000 units at $63.61) (SEC Form 4)

    4 - Loar Holdings Inc. (0002000178) (Issuer)

    3/13/26 3:35:19 PM ET
    $LOAR
    Military/Government/Technical
    Industrials

    $ABL
    $AGIO
    $AKAN
    $APDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Halligan Brian sold $1,913,130 worth of shares (8,292 units at $230.72) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 362,000 units (SEC Form 4)

    4 - HUBSPOT INC (0001404655) (Issuer)

    4/23/26 4:44:33 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Fluor Corp

    4 - NUSCALE POWER Corp (0001822966) (Issuer)

    4/23/26 6:43:04 AM ET
    $SMR
    Metal Fabrications
    Industrials

    SEC Form 4 filed by Chen Jingye

    4 - Sea Ltd (0001703399) (Issuer)

    4/22/26 6:04:20 AM ET
    $SE
    Other Consumer Services
    Consumer Discretionary

    $ABL
    $AGIO
    $AKAN
    $APDN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ABL
    $AGIO
    $AKAN
    $APDN
    Leadership Updates

    Live Leadership Updates

    View All

    Netcapital Appoints Todd Violette as Chief Executive Officer

    BOSTON, MA, April 16, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW)) (the "Company"), a publicly traded fintech company that gives companies access to capital markets infrastructure without institutional-scale fees, today announced that its Board of Directors has appointed Mr. Violette to lead the Company in order to accelerate capital formation, expand platform reach, and build long-term shareholder value. Mr. Violette brings over 25 years of leadership experience across capital markets, fintech and digital asset-related businesses. His recent operating and executive roles have included CEO of CloudCover International, CEO of AppYea Inc., CEO of Vinergy, Chief Investment

    4/16/26 4:05:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Oklo Announces Changes to its Board of Directors and Management Team to Support its Continued Growth

    Oklo welcomes Dr. Mark Peters, David Christian, Derek Kan, and David Park as new directors, bringing decades of experience executing complex and highly technical projects across a range of industries Oklo appoints Michael Thompson as Lead Independent Director Oklo announces plan to transition Pat Schweiger from Chief Technology Officer to a senior technical advisor Oklo Inc. (NYSE:OKLO), an advanced nuclear technology company, today announced changes to its Board of Directors and management team designed to enable Oklo to meet its ambitious deployment goals across its integrated power-fuel-isotopes business. "Over the past two years, we have built distinct business units respons

    4/14/26 4:15:00 PM ET
    $GL
    $OKLO
    $SLI
    Life Insurance
    Finance
    Electric Utilities: Central
    Utilities

    [solidcore] Unveils 2026 Core Collective, Expanding Member Experience Through Leading Wellness Partnerships

    Expanded Partnerships with Celsius, KOIA, Salt & Stone, Thorne, and Tower28 Elevate the [solidcore] Membership Experience [solidcore], the industry-leading boutique strength-training brand, today unveils its 2026 Core Collective, member-exclusive offers and experiences program, designed to enhance member value and extend the brand's impact beyond the studio walls. Through partnerships with Celsius, KOIA, Salt & Stone, Thorne, and Tower 28, Core Collective delivers a curated mix of in-studio and digital experiences and offers that support members across their broader health and wellness routines. Highlights include the introduction of KOIA products in studio fridges nationwide and a dedica

    4/13/26 10:00:00 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    $ABL
    $AGIO
    $AKAN
    $APDN
    Financials

    Live finance-specific insights

    View All

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026

    BRIDGEWATER, N.J., April 23, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its first-quarter 2026 financial results on Thursday, May 7, 2026.Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, May 7, 2026, to discuss financial results and provide a business update.Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7

    4/23/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABL
    $AGIO
    $AKAN
    $APDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D filed by Exicure Inc.

    SC 13D - EXICURE, INC. (0001698530) (Subject)

    11/29/24 5:51:28 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Ocean Power Technologies Inc.

    SC 13G/A - Ocean Power Technologies, Inc. (0001378140) (Subject)

    11/27/24 1:43:24 PM ET
    $OPTT
    Electric Utilities: Central
    Utilities